Axillary reverse lymphatic mapping in breast cancer surgery: a comprehensive review

References

• Noguchi M. Axillary reverse mapping for breast cancer. Breast Cancer Res Treat 2010;119(3):529-35
   PubMed Web of Science ®Google Scholar
• Noguchi M. Axillary reverse mapping for preventing lymphedema in axillary lymph node dissection and/or sentinel lymph node biopsy. Breast Cancer 2010;17(3):155-7
   PubMed Web of Science ®Google Scholar
• Deng H, Chen L, Jia W, et al. Safety study of axillary reverse mapping in the surgical treatment for breast cancer patients. J Cancer Res Clin Oncol 2011;137(12):1869-74
   PubMed Web of Science ®Google Scholar
• Iwase H, Yamamato Y, Kawasoe T, Ibusuki M. Advantage of sentinel lymph node biopsy before neoadjuvant chemotherapy in breast cancer treatment. Surg Today 2009;39:374-80
   PubMed Web of Science ®Google Scholar
• Klimberg VS. A new concept toward the prevention of lymphedema: axillary reverse mapping. J Surg Oncol 2008;97(7):563-4
   PubMed Web of Science ®Google Scholar
• Bedrosian I, Babiera GV, Mittendorf EA, et al. A phase I study to assess the feasibility and oncologic safety of axillary reverse mapping in breast cancer patients. Cancer 2010;116(11):2543-8
   PubMed Web of Science ®Google Scholar
• Khan SA, Lurie RH. Axillary reverse mapping to prevent lymphedema after breast cancer surgery: defining the limits of the concept. J Clin Oncol 2009;27(33):5494-6
   PubMed Web of Science ®Google Scholar
• Thompson M, Korourian S, Henry-Tillman R, et al. Axillary reverse mapping (ARM): a new concept to identify and enhance lymphatic preservation. Ann Surg Oncol 2007;14(6):1890-5
   PubMed Web of Science ®Google Scholar
• Boneti C, Korourian S, Diaz Z, et al. Scientific Impact Award: axillary reverse mapping (ARM) to identify and protect lymphatics draining the arm during axillary lymphadenectomy. Am J Surg 2009;198(4):482-7
   PubMed Web of Science ®Google Scholar
• Casabona F, Bogliolo S, Valenzano M, et al. Feasibility of axillary reverse mapping during sentinel lymph node biopsy in breast cancer patients. Ann Surg Oncol 2009;16(9):2459-63
   PubMed Web of Science ®Google Scholar
• Noguchi M, Yokoi M, Nakano Y. Axillary reverse mapping with indocyanine fluorescence imaging in patients with breast cancer. J Surg Oncol 2010;101(3):217-21
   PubMed Web of Science ®Google Scholar
• Boneti C, Korourian S, Bland K, et al. Axillary reverse mapping: mapping and preserving arm lymphatics may be important in preventing lymphedema during sentinel lymph node biopsy. J Am Coll Surg 2008;206(5):1038-42
   PubMed Web of Science ®Google Scholar
• Noguchi M, Noguchi M, Nakano Y, et al. Axillary reverse mapping using a fluorescence imaging system in breast cancer. J Surg Oncol 2012;105(3):229-34
   PubMed Web of Science ®Google Scholar
• Giuliano AE, Hunt KK, Ballman KV, et al. Axillary dissection versus no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. J Am Med Assoc 2011;305(6):569-75
   PubMed Web of Science ®Google Scholar
• Giuliano AE, McCall L, Beitsch P, et al. Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial. Ann Surg 2010;252(3):426-32
   PubMed Web of Science ®Google Scholar
• Nos C, Kaugmann G, Clough KB, et al. Combined axillary reverse mapping (ARM) technique for breast cancer patients requiring axillary dissection. Ann Surg Oncol 2008;15(9):2550-5
   PubMed Web of Science ®Google Scholar
• Ikeda K, Ogawa Y, Komatsu H, et al. Evaluation of the metastatic status of lymph nodes identified using axillary reverse mapping in breast cancer patients. World J Surg Oncol 2012;10:233
   PubMed Web of Science ®Google Scholar
• Tausch C, Baege A, Dietrich D, et al. Can axillary reverse mapping avoid lymphedema in node positive breast cancer patients? Eur J Surg Oncol 2013;39(8):880-6
   PubMed Web of Science ®Google Scholar
• Ponzone R, Mininanni P, Cassina E, Sismondi P. Axillary reverse mapping in breast cancer: can we spare what we find? Ann Surg Oncol 2008;15(1):390-1
   PubMed Web of Science ®Google Scholar
• Ponzone R, Cont NT, Maggiorotto F. Extensive nodal disease may impair axillary reverse mapping in patients with breast cancer. J Clin Oncol 2009;27(33):5547-51
   PubMed Web of Science ®Google Scholar
• Klompenhouwer EG, Gobardhan PD, Beek MA, et al. The clinical relevance of axillary reverse mapping (ARM): study protocol for a randomized controlled trial. Trials 2013;14:111
   PubMedGoogle Scholar
• Rubio IT, Cebrecos I, Peg V, et al. Extensive nodal involvement increases the positivity of blue nodes in the axillary reverse mapping procedure in patients with breast cancer. J Surg Oncol 2012;106(1):89-93
   PubMed Web of Science ®Google Scholar
• Han JW, Seo YJ, Choi JE, et al. The efficacy of arm node preserving surgery using axillary reverse mapping for preventing lymphedema in patients with breast cancer. J Breast Cancer 2012;15(1):91-7
   PubMed Web of Science ®Google Scholar
• Pavlista D, Eliska O. Relationship between the lymphatic drainage of the breast and the upper extremity: a postmortem study. Ann Surg Oncol 2012;19(11):3410-15
   PubMed Web of Science ®Google Scholar
• Pavlista D, Eliska O. Analysis of direct oil contrast lymphography of upper limb lymphatics traversing the axilla - a lesson from the past - contribution to the concept of axillary reverse mapping. Eur J Surg Oncol 2012;38(5):390-4
   PubMed Web of Science ®Google Scholar
• Casabona F, Bogliolo S, Ferrero S, et al. Axillary reverse mapping in breast cancer: a new microsurgical lymphatic-venous procedure in the prevention of arm lymphedema. Ann Surg Oncol 2008;15(11):3318-19
   PubMed Web of Science ®Google Scholar
• Whelan Y, Ackerman I, Chapman JW, et al. MA.20: An intergroup trial of regional nodal irradiation in early breast cancer. J Clin Oncol ASCO Annual Meeting Proceed (Post-Meeting Edition) 2011;29
   Google Scholar
• Fehm T, Helms G, Banys M, Kühn T. Management of the axilla for ipsilateral breast cancer recurrence after previous sentinel lymph node biopsy and breast conserving therapy. Gynecol Surg 2011;8:13-18
   Google Scholar
• Ahmed RL, Prizment A, Lazovich D, et al. Lymphedema and quality of life in breast cancer survivors: the Iowa Women’s Health Study. J Clin Oncol 2008;26:5689-96
   PubMed Web of Science ®Google Scholar
• Klompenhouwer EG, Gobardhan PD, Beek MA, et al. The clinical relevance of axillary reverse mapping (ARM): study protocol for a randomized controlled trial. Trials 2013;14:111
   PubMedGoogle Scholar
• Boughey JC, Suma VJ, Mittendorf EA, et al. Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer. JAMA 2013;310(14):1455-61
   PubMed Web of Science ®Google Scholar
• Kuehn Y, Bauerfeind I, Fehm T, et al. Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study. Lancet Oncol 2013;2045(13):609-18
   Google Scholar
• Gobardhan PD, Wijsman JH, van Dalen T, et al. ARM: axillary reverse mapping - the need for selection of patients. Eur J Surg Oncol 2012;38(8):657-61
   PubMed Web of Science ®Google Scholar